Mestag Therapeutics is exploiting emerging insights in the role of fibroblast subpopulations to develop pioneering transformative therapies in inflammatory disease and oncology.
Member count: 11-50
Total raised: $56M
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | SV Health ... | svhealthin... |
| 07.08.2021 | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 03.08.2021 | Seed | $45M | - | cambridgen... |
| 27.04.2021 | Seed | $11M | - | svhealthin... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 27.09.2021 | FIERCE BIO... | Cambridge, UK, 27 September 20... | - | - | svhealthin... |
| 04.08.2021 | Mestag The... | Mestag Therapeutics extends se... | - | - | cambridgen... |
| 03.08.2021 | Mestag The... | - Oversubscribed seed round su... | - | - | svhealthin... |
| 03.08.2021 | Forbion Le... | Naarden, The Netherlands, 3 Au... | - | - | forbion.co... |
| 18.05.2021 | Mestag The... | Cambridge, UK, 18 May 2021 – M... | - | - | svhealthin... |
| 20.04.2021 | Mestag The... | - Backed by leading healthcare... | - | - | svhealthin... |